Identifying New Persistent and Bioaccumulative Organics Among Chemicals in Commerce II: Pharmaceuticals
- 8 July 2011
- journal article
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 45 (16), 6938-6946
- https://doi.org/10.1021/es201196x
Abstract
The goal of this study was to identify commercial pharmaceuticals that might be persistent and bioaccumulative (P&B) and that were not being considered in current wastewater and aquatic environmental measurement programs. We developed a database of 3193 pharmaceuticals from two U.S. Food and Drug Administration (FDA) databases and some lists of top ranked or selling drugs. Of the 3193 pharmaceuticals, 275 pharmaceuticals have been found in the environment and 399 pharmaceuticals were, based upon production volumes, designated as high production volume (HPV) pharmaceuticals. All pharmaceuticals that had reported chemical structures were evaluated for potential bioaccumulation (B) or persistence (P) using quantitative structure property relationships (QSPR) or scientific judgment. Of the 275 drugs detected in the environment, 92 were rated as potentially bioaccumulative, 121 were rated as potentially persistent, and 99 were HPV pharmaceuticals. After removing the 275 pharmaceuticals previously detected in the environment, 58 HPV compounds were identified that were both P&B and 48 were identified as P only. Of the non-HPV compounds, 364 pharmaceuticals were identified that were P&B. This study has yielded some interesting and probable P&B pharmaceuticals that should be considered for further study.Keywords
This publication has 22 references indexed in Scilit:
- Environmental Risk Assessment of Emerging Pollutants in Water: Approaches Under Horizontal and Vertical EU LegislationCritical Reviews in Environmental Science and Technology, 2011
- Phosphodiesterase type V inhibitors: Occurrence and fate in wastewater and sewage sludgeWater Research, 2010
- Identifying New Persistent and Bioaccumulative Organics Among Chemicals in CommerceEnvironmental Science & Technology, 2010
- A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatmentJournal of Environmental Monitoring, 2010
- Environmental footprint of pharmaceuticals: The significance of factors beyond direct excretion to sewersEnvironmental Toxicology and Chemistry, 2009
- Revisiting Bioaccumulation Criteria for POPs and PBT AssessmentsIntegrated Environmental Assessment and Management, 2009
- Pharmaceutical-residue analysisTrAC Trends in Analytical Chemistry, 2007
- Are There Other Persistent Organic Pollutants? A Challenge for Environmental ChemistsEnvironmental Science & Technology, 2006
- Ecotoxicology of human pharmaceuticalsAquatic Toxicology, 2006
- Predicting ready biodegradability in the Japanese ministry of international trade and industry testEnvironmental Toxicology and Chemistry, 2000